Semaglutide FLOW Kidney and Heart Findings: What Patients Should Know 6th June 20266th June 2026 by Living Diabetes Editorial A new FLOW analysis reports that semaglutide kidney and all-cause death benefits were consistent across cardiovascular-risk groups in adults with type 2 diabetes and chronic kidney disease.
Anemia and Diabetes: How Kidney Disease Can Affect Blood Counts 6th June 20264th April 2026 by Living Diabetes Editorial Team Kidney disease can contribute to anemia in diabetes. Learn symptoms, testing, causes, and why treatment must be individualized.
Finerenone (Kerendia): Kidney and Heart Protection in Type 2 Diabetes 6th June 20262nd April 2026 by Living Diabetes Editorial Team Finerenone may reduce kidney and heart risks in CKD linked with type 2 diabetes. Learn who it is for, potassium monitoring, and cautions.
Hydration and Diabetes: Water, Blood Sugar, and Kidney Safety 6th June 20261st April 2026 by Living Diabetes Editorial Team Practical hydration guide for people with diabetes, covering high glucose, sick days, heat, kidney disease, fluid limits, and urgent symptoms.
GLP-1 Medicines and Kidney Protection: What the Evidence Shows 6th June 202629th March 2026 by Living Diabetes Editorial Team Some GLP-1 medicines have kidney outcome evidence in type 2 diabetes, but benefits are drug-specific. Learn the practical caveats.
Diabetes and Kidney Disease: What to Know Early 3rd June 202628th March 2026 by Living Diabetes Editorial Team Diabetic kidney disease can be silent early. Learn screening tests, risk factors, prevention steps, and when to seek care.
